Pharmacokinetics of Single and Multiple Escalating Doses of Aramchol Administered Under Fed Conditions in Healthy Chinese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2016

Conditions
Healthy Volunteers
Interventions
DRUG

Aramchol

Part A: Aramchol oral tablets at 400 mg or 600 mg single dose Part B: Aramchol oral tablets at 400 mg or 600 mg multiple dose for 10 consecutive days.

DRUG

Placebo

Part A: Placebo oral tablets single dose Part B: Placebo oral tablets multiple dose for 10 consecutive days.

Trial Locations (1)

90630

WCCT Global, LLC., Cypress

All Listed Sponsors
collaborator

WCCT Global

INDUSTRY

collaborator

Alpha IRB

UNKNOWN

collaborator

Analyst Research Laboratories

OTHER

collaborator

Kramer Consulting, LLC

OTHER

collaborator

Diamond Pharma Services Regulatory Affairs Consultancy

OTHER

lead

Galmed Pharmaceuticals Ltd

INDUSTRY